Module 9 2024

03/09/2024

Module 9: Registration of Biological, Biotechnology and Advanced Therapy Products

Regulation of Vaccines

Andrew Deavin, Senior Director, Global Regulatory Policy Lead Supporting Vaccines, GSK

11 September 2024

The Organisation for Professionals in Regulatory Affairs The Organisation for

Professionals i Regulatory Affairs

1

Disclosure Statement

Andrew Deavin is an employee of the GSK group of companies and holds shares in GSK The opinions expressed in this presentation and on the following slides are solely those of the presenter and not necessarily those of GSK

The Organisation for Professionals in Regulatory Affairs The Organisation for

Professionals i Regulatory Affairs

2

1